Wanbury Ltd - 524212 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Wanbury's Board of Directors will convene on August 11, 2026, to review and approve the unaudited financial results for the first quarter of FY27. This meeting will address the company's financial performance for the period ending June 30, 2026.
Aug 03 2026 17:25:26
Wanbury Ltd - 524212 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Wanbury Limited has received a 'No DMF deficiency letter' from the USFDA, a key regulatory clearance for its multiple Abbreviated New Drug Applications (ANDAs) involving Metformin HCl API. This is a positive development for its US market presence.
Jul 30 2026 10:11:39
Wanbury Ltd - 524212 - Intimation Of Completion Of Inspection By The United States Food And Drug Administration (USFDA) At The Company''s Facility At Tanuku, West Godavari District, Andhra Pradesh
Wanbury's manufacturing facility in Tanuku, Andhra Pradesh, was inspected by the USFDA from July 13 to July 17, 2026. The inspection concluded with six observations on Form 483, to which the company will respond. Wanbury does not foresee a material impact on operations or financial performance.
Jul 22 2026 15:15:00
Wanbury Ltd - 524212 - Intimation Of Completion Of Inspection By The United States Food And Drug Administration (USFDA) At The Company''s Facility At Tanuku, West Godavari District, Andhra Pradesh
Wanbury's Tanuku facility was inspected by the USFDA from July 13-17, 2026. The inspection concluded with the issuance of a Form 483 detailing six observations, to which the company will respond.
Jul 20 2026 16:14:34
Wanbury Ltd - 524212 - Resolution Passed Through Circulation By The Board Of Directors Of The Company
Wanbury's Board has approved the early redemption of Rs. 180 crore worth of its 12.5% unlisted, secured Non-Convertible Debentures (NCDs). The original maturity date was February 28, 2030, indicating a pre-scheduled debt reduction. The record date for this early redemption is set for June 20, 2026.
Jul 15 2026 17:43:37
Wanbury Ltd - 524212 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Catalyst Trusteeship Ltd, acting as Debenture Trustee, released a Non-Disposal Undertaking (NDU) on 3,683,488 shares of Wanbury Ltd on July 09, 2026. This release covers 10.54% of the company's total voting capital.
Jul 13 2026 19:26:56
Wanbury Ltd - 524212 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Wanbury Ltd reported the release of pledge on 8.52 million equity shares, equivalent to 24.39% of its voting capital. These shares were held by Expert Chemicals (India) Private Limited.
Jul 09 2026 11:01:32
Wanbury Ltd - 524212 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Wanbury Ltd reported the release of pledge on 8.52 million equity shares, equivalent to 24.39% of its voting capital. These shares were held by Expert Chemicals (India) Private Limited.
Jul 09 2026 10:36:55
Read More